SynoJoynt™ 1% Sodium Hyaluronate

SynoJoynt™ is a high molecular weight, non-crosslinked sodium hyaluronate derived from bacterial fermentation with excellent safety and tolerability.¹ It is indicated for the treatment of pain from osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics.

Explore the new

^Reference:

^{1. US Food and Drug Administration. Summary of safety and effectiveness (SSED) for SynoJoynt. Accessed January 5, 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170016B.pdf}

^INDICATIONS

^{SYNOJOYNT is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).}

^{CONTRAINDICATIONS}

• ^{Do not use SYNOJOYNT to treat patients who have a known hypersensitivity to hyaluronan preparations.}
• ^{Do not use to treat patients with knee joint infections or to treat patients with infections or skin disease in the area of the injection site.}

^WARNINGS

• ^{Do not concomitantly use disinfectants containing quaternary ammonium salts or chlorhexidine for skin preparations because hyaluronan can precipitate in their presence.}
• ^{Do not inject intravascularly because intravascular injections of SYNOJOYNT may cause systemic adverse events.}